March 2018 - Page 3 of 6 - CannabisNewsWire

ThursdayMar 15, 2018 4:10 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Continues to Advance its Agenda

Owns worldwide rights for patented formulations and drug delivery technologies Develops and commercializes therapeutic pharmaceuticals and nutraceuticals Strategic agenda to become one of world’s only vertically integrated cannabis biotechs With worldwide rights for unique drug delivery platforms in place, Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is rapidly building a disruptive, vertically integrated biotechnology company. Advancing this agenda, the company recently announced that it has retained Cannabis Compliance Inc. to submit an application to Health Canada for a dealer’s license on behalf of Pivot’s acquisition target, Agro-Biotech Inc. (http://cnw.fm/0K5Xn). In February, Pivot announced that its entry into a…

ThursdayMar 15, 2018 1:46 pm

Global Payout Inc. (GOHE) Subsidiary’s Public Initial Blockchain Offering Showcases Company’s Fintech Capabilities

SEC-regulated offering of digital tokens Balance sheet funding program for fintech investments Issuer (MoneyTrac subsidiary) focused on fintech for cannabis industry With a public initial blockchain offering (“PIBCO”) now underway, Global Payout Inc. (OTC: GOHE) is showcasing its innovative prowess. A PIBCO is similar to an initial coin offering, except that the coins or tokens involved are treated as securities under federal laws. As a result, the rights and benefits represented by those digital assets are subject to SEC rules. Under the PIBCO, Global Payout’s majority-owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”), will offer tokens that provide share warrants of MoneyTrac…

ThursdayMar 15, 2018 12:50 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Secures Australian Importation Permit in Support of Research into Sol-gels

Research will be conducted at PACE, a leading pharmaceutical research center in Australia PreveCeutical’s unique technology promises to be the first FDA-approved, CBD-based nose-to-brain delivery system using a Sol-gel platform Groundbreaking technology outstrips the benefits of any other delivery mechanism On March 13, 2018, PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and Aurora Cannabis Inc. (OTCQB: ACBFF) (TSX: ACB) (FSE: 21P) announced that they had received three permits for the importation of cannabis plant material into Australia for research purposes. The permits were granted by the Australian Government’s Department of Health, allowing shipment from Canada by Aurora Cannabis…

WednesdayMar 14, 2018 3:40 pm

ChineseInvestors.com, Inc. (CIIX) CEO Discusses the Company’s Future on MoneyTV

Warren Wang, founder and CEO of ChineseInvestors.com (OTCQB: CIIX), was recently interviewed on MoneyTV with Donald Baillargeon. The company, in addition to being a leader in education products and services for the Chinese-speaking community in North America and elsewhere, has recognized and seized the opportunity in the growing cannabis industry. With a focus on cryptocurrency and financial education, as well as a new private company spinoff of its hemp assets, CIIX is a company to watch. Wang spoke of upcoming changes in both the cannabis and cryptocurrency markets. Anticipating the potential revenue of the company’s hemp assets for the 2018-2019…

WednesdayMar 14, 2018 1:59 pm

Medical Cannabis Payment Solutions’ (REFG) Green is Designed to Grow

Proprietary payment platform customized for legal cannabis merchants makes it a gateway to the industry for electronic money transactions CEO Jeremy Roberts says that Green platform takes state-sanctioned cannabis into the 21st century of electronic banking and financial services Green platform offers ease of cash management to merchants while enabling consumers and patients to purchase electronically, even with cryptocurrency Medical Cannabis Payment Solutions’ (OTC: REFG) Green platform, a top tier digital payment processing system, is designed to bring legalized cannabis and its cash management for licensed merchants and dispensaries into the world of digital financial services. “What we’re launching is…

WednesdayMar 14, 2018 12:12 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Completes $1.5 Million Private Placement

Proceeds to be used for development of new cultivation and processing project in New Brunswick A boost to operating capital Canada plans to legalize the extraction of cannabinoids from hemp in mid-2018 Market for hemp CBD products is predicted to grow to $450 million by 2020 Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), a company focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets, announced on March 7, 2018, that it had closed a non-brokered private placement, consisting of 12.5 million units at a price of $0.12 per unit, to raise…

TuesdayMar 13, 2018 3:23 pm

Earth Science Tech, Inc. (ETST): Transparency, Scientific Research and Future Products

Received grant from Government of Québec through Canno Inno Laboratories subsidiary Canna Inno Laboratories enhances collaboration between the company’s resources in Canada and the U.S. while providing access to grants Sound scientific research and transparent studies Earth Science Tech, Inc. (OTC: ETST), a Florida-based biotechnology company focused on cannabis, industrial hemp and cannabinoid research and development for nutraceuticals, pharmaceuticals and medical devices, announced last week that its subsidiary, Canna Inno Laboratories Inc., has received a grant from the Government of Québec for innovation in the pharmaceutical industry. ETST plans to apply for additional funding under Canada’s Scientific Research and Experimental…

TuesdayMar 13, 2018 1:40 pm

EVIO, Inc. (EVIO) on Track for Exponential Growth within the Booming Legal Cannabis Industry

Cannabis testing comprises about five percent of the multibillion-dollar cannabis industry Company currently operates nine testing labs in five U.S. states Plans in view to double number of operating labs by year-end 2018 and potentially expand into Canada Leading cannabis testing services provider EVIO, Inc. (OTCQB: EVIO) is on a growth trajectory that is bounded only by the growth limits of the blossoming cannabis industry itself. In other words, things are looking good for EVIO. Cannabis testing services like those offered by EVIO currently comprise about five percent of the total marijuana market, which is projected to reach $31.4 billion…

TuesdayMar 13, 2018 12:24 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Finding Ever-Growing Ways to Administer Cannabis Benefits

Pivot Pharmaceuticals developing disruptive formulations for cannabis-infused markets Company’s goal is to strengthen dosage predictability and improve product stability Recent acquisitions and planned acquisitions give Pivot vertical position in multi-billion-dollar industries Despite recent setbacks to efforts seeking broader marijuana legalization in North America (http://cnw.fm/zM2Mc), the tide of social preferences for cannabis availability, even in recreational applications, continues to advance (http://cnw.fm/tT62e). Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is helping to advance efforts to legitimize the drug’s use, both in medicinal and recreational settings, by pursuing ever-increasing methods for consuming cannabis’s derivatives in quantities with predictable outcomes. “Pivot’s goal…

MondayMar 12, 2018 4:13 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Linker Tech Mimics Body’s Production of Pain Relieving Peptides

Developing pain relievers that mimic body’s natural pain relief peptides Other programs include development of treatments for diabetes, synthetization of blue scorpion venom and study of a novel cannabinoid delivery platform Revenues from international licensing strategy The discovery of endomorphins in 1997 was a remarkable reminder of the human body’s wondrous nature. Endomorphins are naturally produced morphine-like substances with an affinity for the µ-opioid receptors in the brain, which fortunately happen to be the best places to alleviate pain. With a potency that far exceeds morphine, these endogenous substances are the body’s first line of defense against pain and stress.…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

Month: March 2018